Screener
KBE vs XBI
State Street SPDR S&P Bank ETF vs State Street SPDR S&P Biotech ETF
Key differences
- XBI is significantly larger than KBE — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, KBE has delivered higher annualized returns.
Side-by-side comparison
| KBE | XBI | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.35% |
| Fund size (AUM) | $1.5B | $8.3B |
| Since | 2005 | 2006 |
| Dividend yield | 2.31% | 0.34% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +23.8% | +70.7% |
| CAGR 3Y | +26.2% | +16.6% |
| CAGR 5Y | +6.1% | +1.6% |
| Sharpe 3Y | 0.89 | 0.57 |
| Volatility 1Y | 21.59% | 25.16% |
| Max drawdown | -53.14% | -63.89% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to KBE and XBI
Explore further